Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Strategic Entities
Domestic Funds
Held in 21 Schemes (13.98%)
Foreign Institutions
Held by 27 Foreign Institutions (6.8%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2025)
Net Profit:
-15 Million
Pharmaceuticals & Biotechnology
USD 36 Million ()
NA
0.00%
-1.06
-999,999.00%
0.46






